.jpg "Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery")
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text
Aggressive Surgery Increases Survival with Low-Grade Brain Tumors | UC San Francisco
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas - Modern Pathology
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Astrocytoma Treatment & Management: Approach Considerations, Surgical Care, Medical Care
A) Kaplan-Meier plots of 10-year survival by time period for patients... | Download Scientific Diagram
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis - ScienceDirect
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram
Glioma - Wikipedia
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
Brain Tumour Registry of Canada (BTRC): Survival and Prevalence Report 2010–2017 June 2022
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research
Advantages of gross total resection in patients with astrocytoma: A population‑based study
